The US CDC and FDA have lifted their recommended pause on use of Johnson & Johnson's coronavirus vaccine with a condition that it will now include a safety label warning that its vaccine comes with blood clot risks.
J&J vaccination shots were paused last week after nine rare side effects were reported. Seven of the reactions were seen in women.
Five medical experts voted in a committee meeting on whether to lift pause on J&J covid-19 vaccine.
Two U.S. officials suggeste...
